This inventor holds 34 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Antibody Therapeutics. Top assignees: Smithkline Beecham Corporation, Eli Lilly and Company, Johns Hopkins University. Active years: 1999-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Linfield, PA (US) (1999 - 2007)
- Fortville, IN (2011)
- Fortville, IN (US) (2008 - 2012)
- Spiceland, IN (US) (2015 - 2024)
- Indianapolis, IN (US) (2024)
Company Filing History:
19 out of 2,198 
13 out of 4,517 
5 out of 3,806 
Years Active: 1999-2024
Areas of Expertise:
Title: **Kristine Kay Kikly: Innovator in Biopharmaceutical Patents**
Introduction
Kristine Kay Kikly, a prominent inventor based in Fortville, Indiana, has made significant contributions to the field of biopharmaceuticals, holding a total of 34 patents throughout her career. Her work focuses on innovative therapeutic solutions, particularly in the treatment of complex medical conditions.
Latest Patents
Among her recent inventions, two notable patents stand out. The first is for "PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa." This patent provides methods and uses for antibodies targeting ELR+ CXC chemokines specifically aimed at treating this chronic skin condition. Alongside this, she has developed the "Anti-CD11D antibodies and uses thereof," which details antibodies to human CD11d and describes their application in treating central nervous system trauma, including spinal cord injury and traumatic brain injury, as well as addressing systemic inflammatory responses following such injuries.
Career Highlights
Kristine has had a notable career, having worked with renowned companies in the pharmaceutical sector, including SmithKline Beecham Corporation and Eli Lilly and Company. Her experience in these organizations has allowed her to develop and patent cutting-edge biopharmaceutical solutions that address significant health challenges.
Collaborations
Throughout her career, Kristine has collaborated with several talented individuals, notably Catherine Brautigam Beidler and Connie L. Erickson-Miller. These partnerships have contributed to her innovative approach to research and development in her field.
Conclusion
Kristine Kay Kikly's dedication to innovation in biopharmaceuticals is clear through her extensive patent portfolio and collaborations. Her work not only demonstrates her expertise but also her commitment to developing therapies that can significantly improve patient outcomes in challenging medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile